MedTrace Logo

Kidney Disease After COVID-19

NCT05328986 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1753

Last updated 2025-07-20

No results posted yet for this study

Summary

To understand the long-term epidemiology, develop effective risk-prediction and stratification tools, and understand the pathobiology of kidney disease in COVID-19 survivors.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Evren U. Azeloglu, PhD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-04
Primary Completion
2024-01-04
Completion
2024-01-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05328986 on ClinicalTrials.gov